Editorial Comment: Temporary Withholding of Antithrombotic Therapy Before a Core Needle Breast or Axillary Biopsy Does Not Reduce the Risk of Postbiopsy Hematoma
AJR Am J Roentgenol
.
2023 Oct;221(4):448.
doi: 10.2214/AJR.23.29626.
Epub 2023 May 17.
Author
Hannah Perry
1
Affiliation
1
University of Vermont Medical Center, Larner College of Medicine at the University of Vermont, Burlington, VT, Hannah.Perry@UVMHealth.org.
PMID:
37195796
DOI:
10.2214/AJR.23.29626
No abstract available
Publication types
Comment
MeSH terms
Biopsy
Breast* / pathology
Fibrinolytic Agents* / adverse effects
Hematoma / diagnostic imaging
Hematoma / etiology
Hemorrhage / chemically induced
Hemorrhage / pathology
Hemorrhage / prevention & control
Humans
Substances
Fibrinolytic Agents